Paratek Pharmaceuticals Announces Presentation of Several New Studies of NUZYRA(R) (omadacycline) Across a Range of Serious Infections at IDWeek 2024

— Highlights include data from clinical, non-clinical and microbiology programs, real-world patient use and a five-year microbiologic surveillance study of NUZYRA BOSTON, Oct. 14, 2024 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on providing innovative medical therapies that create positive patient stories in the hospital, community and public health settings, announces that […]

Hispanic homeowners narrow home value gap to smallest margin on record

Recent Zillow® research shows Hispanic homeowners making strides in narrowing the home value gap with white homeowners over the past two years, regaining ground lost during the pandemic. The gap is now the narrowest ever observed. https://mma.prnewswire.com/media/844956/Zillow.jpg Hispanic-owned homes are currently worth 11.9% less than homes owned by non-Hispanic white households, down from 12.1% last

PSEG To Announce Third Quarter 2024 Financial Results On November 4

Public Service Enterprise Group Incorporated (PSEG) will host its third quarter 2024 earnings call at 11:00 a.m. ET on Monday, November 4, during which management will discuss third quarter financial results,financial guidance, capital investments, regulatory activities,and other important matters. https://mma.prnewswire.com/media/448542/PSEG_Logo.jpg The audio webcast can be accessed at that time, along with accompanying presentation materials, on

ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2024

WINSTON-SALEM, N.C., Oct. 14, 2024 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company”), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that the Company will present five posters, including one late-breaking clinical trial, at the upcoming American Society of Nephrology’s (ASN) Kidney Week being held

MariMed Commences Cultivation Operations in Mt. Vernon, Illinois Grow Facility

NORWOOD, Mass., Oct. 14, 2024 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator, today announced it commenced operations in its new cultivation facility in Mt. Vernon, Illinois. The first harvest is expected in early 2025, at which time the Company will sell its award-winning Nature’s Heritage

Hillman Sets Third Quarter 2024 Earnings Release and Results Presentation Date

CINCINNATI, Oct. 14, 2024 (GLOBE NEWSWIRE) — Hillman Solutions Corp. (Nasdaq: HLMN) (“Hillman”), a leading provider of hardware products and merchandising solutions, plans to host a conference call to discuss its results for the thirteen weeks ended September 28, 2024 on Tuesday, November 5, 2024 at 8:30 a.m. Eastern Time. Hillman will issue its earnings

Aqua-Tots Swim School Expands to New York, Opening First Location in Amherst

Amherst, NY, Oct. 14, 2024 (GLOBE NEWSWIRE) — Aqua-Tots Swim School, the largest international swim school franchise, is proud to announce that its first facility in the state of New York is now open in the city of Amherst. The 7,000-square-foot facility offers lessons Monday through Saturday at a variety of times convenient for parents.

SystImmune, Inc. Announces FDA Clearance of IND Application for BL-M11D1 in Relapsed/Refractory Acute Myeloid Leukemia

SystImmune, Inc (SystImmune), a clinical-stage biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for BL-M11D1, an antibody-drug conjugate (ADC) binding CD33, a protein on myeloid cells. The IND supports the initiation of a Phase 1 clinical trial, BLM11D1-HM-101, to evaluate the safety, tolerability, pharmacokinetics,

Torrid Holdings Inc. (CURV) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Torrid Holdings Inc. ("Torrid Holdings Inc.") (NYSE:CURV) concerning possible violations of federal securities laws. On October 7, 2024, Torrid announced the termination of "Ms. Elizabeth Muñoz-Guzman, the [Company’s] Executive Vice President and Chief

Shareholders that lost money on Nomura Holdings, Inc.(NMR) should contact Levi & Korsinsky about Securities Fraud Investigation – NMR

NEW YORK, NY / ACCESSWIRE / October 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Nomura Holdings, Inc. ("Nomura Holdings, Inc.") (NYSE:NMR) concerning possible violations of federal securities laws. Media outlets reported on September 30, 2024, that Nomura was excluded as lead manager for several yen bond deals

Scroll to Top